Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KRAS | P01116 | 20/20 | 0.79 |
| ▸ | VHL | P40337 | 1/20 | 0.56 |
| ▸ | CDK7 | P50613 | 1/20 | 0.56 |
| ▸ | CCNH | P51946 | 1/20 | 0.56 |
| ▸ | MNAT1 | P51948 | 1/20 | 0.56 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23282234 | 0.94 | KRAS (0.85) | KRASVHLCDK7CCNHMNAT1 | |
| SCHEMBL23282388 | 0.92 | KRAS (0.79) | KRASVHLCDK7CCNHMNAT1 | |
| SCHEMBL23282275 | 0.91 | KRAS (0.81) | KRAS | |
| SCHEMBL23282263 | 0.91 | KRAS (0.81) | KRAS | |
| SCHEMBL23275904 | 0.91 | KRAS (0.74) | KRASVHLCDK7CCNHMNAT1 | |
| SCHEMBL23275870 | 0.91 | KRAS (0.74) | KRASVHLCDK7CCNHMNAT1 | |
| SCHEMBL23275931 | 0.91 | KRAS (0.74) | KRASVHLCDK7CCNHMNAT1 | |
| SCHEMBL23282336 | 0.91 | KRAS (0.79) | KRASVHLCDK7CCNHMNAT1 | |
| SCHEMBL23285848 | 0.91 | KRAS (0.79) | KRASVHLCDK7CCNHMNAT1 | |
| SCHEMBL23282370 | 0.91 | KRAS (0.77) | KRAS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021078312-A1 | CYCLOALKYL AND HETERO-CYCLOALKYL INHIBITORS, PREPARATION METHODS THEREFOR, AND USE THEREOF | 苏州泽璟生物制药股份有限公司 | 2021-04-29 | — | — | WO | disclosed |
| WO-2021078285-A1 | CYCLOALKYL-BASED AND HETEROCYCLOALKYL-BASED INHIBITORS, PREPARATION METHOD THEREFOR AND USE THEREOF | 苏州泽璟生物制药股份有限公司 | 2021-04-29 | — | — | WO | disclosed |